Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed‐effects to characterize and quantify variability in drug pharmacokinetics

C Bon, PL Toutain, D Concordet… - Journal of veterinary …, 2018 - Wiley Online Library
A common feature of human and veterinary pharmacokinetics is the importance of
identifying and quantifying the key determinants of between‐patient variability in drug …

Developing exposure/response models for anticancer drug treatment: special considerations

DR Mould, AC Walz, T Lave, JP Gibbs… - CPT: pharmacometrics …, 2015 - Wiley Online Library
Anticancer agents often have a narrow therapeutic index (TI), requiring precise dosing to
ensure sufficient exposure for clinical activity while minimizing toxicity. These agents …

How to disentangle psychobiological stress reactivity and recovery: A comparison of model-based and non-compartmental analyses of cortisol concentrations

R Miller, JG Wojtyniak, LJ Weckesser… - …, 2018 - Elsevier
This article seeks to address the prevailing issue of how to measure specific process
components of psychobiological stress responses. Particularly the change of cortisol …

Beyond deterministic models in drug discovery and development

I Irurzun-Arana, C Rackauckas, TO McDonald… - Trends in …, 2020 - cell.com
The model-informed drug discovery and development paradigm is now well established
among the pharmaceutical industry and regulatory agencies. This success has been mainly …

A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based …

MW van Hoogdalem, SL Wexelblatt, HT Akinbi… - Pharmacology & …, 2022 - Elsevier
Physiologically-based pharmacokinetic (PBPK) modeling has emerged as a useful tool to
study pharmacokinetics (PK) in special populations, such as pregnant women, fetuses, and …

A semimechanistic model of the bactericidal activity of high-dose isoniazid against multidrug-resistant tuberculosis: results from a randomized clinical trial

K Gausi, EH Ignatius, X Sun, S Kim… - American journal of …, 2021 - atsjournals.org
Rationale: There is accumulating evidence that higher-than-standard doses of isoniazid are
effective against low-to-intermediate–level isoniazid-resistant strains of Mycobacterium …

Does the pharmacology of oxycodone justify its increasing use as an analgesic?

KT Olkkola, VK Kontinen, TI Saari, EA Kalso - Trends in pharmacological …, 2013 - cell.com
Oxycodone is a semisynthetic opioid analgesic that is increasingly used for the treatment of
acute, cancer, and chronic non-malignant pain. Oxycodone was synthesized in 1917 but its …

Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point

ECY Hilton, PG Baverel, A Woodcock… - Journal of allergy and …, 2013 - Elsevier
Background Inhaled capsaicin elicits cough reproducibly in human subjects and is widely
used in the study of cough and antitussive therapies. However, the traditional end points C2 …

[HTML][HTML] Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model

DC Kirouac, G Schaefer, J Chan, M Merchant… - NPJ systems biology …, 2017 - nature.com
Approximately 10% of colorectal cancers harbor BRAF V600E mutations, which
constitutively activate the MAPK signaling pathway. We sought to determine whether ERK …

[HTML][HTML] Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective

CG Wilson, L Aarons, P Augustijns, J Brouwers… - European Journal of …, 2022 - Elsevier
This collection of contributions from the European Network on Understanding
Gastrointestinal Absorption-related Processes (UNGAP) community assembly aims to …